Administration of a Selective Antagonist for Pituitary Adenylate Cyclase‐Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat
Neuropsychopharmacology Reports · 2025
DOI: 10.1002/npr2.12514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2025. Verfasst von Kaito Sato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Animal Behavior and Environmental Science, Graduate School of Agriculture, Meiji University, Kawasaki, Japan. Hauptthemen laut MEDLINE: Hippocampus, Pituitary Adenylate Cyclase-Activating Polypeptide, Anxiety, Rats, Sprague-Dawley. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Meiji University International Collaborative Research Promotion Project, Japan, JSPS KAKENHI.
Abstract (Originalsprache)
Pituitary adenylate cyclase‐activating polypeptide (PACAP) affects rodents' stress‐related behaviors, such as anxiety‐like behavior or fear conditioning. However, previous studies have investigated the effect of intracerebroventricular, but not hippocampal, injection of this PAC1R‐selective antagonist (PACAP‐6‐38) on anxiety‐like behavior. However, it has been reported that administration of PACAP‐6‐38 to the dorsal hippocampus reduces the fear response in a fear conditioning test. Therefore, this study aimed to determine whether the effect of dorsal hippocampal PACAP‐6‐38 injection in Sprague–Dawley rats can affect anxiety‐like behavior assessed by an elevated plus‐maze test. As a result, rats treated with PACAP‐6‐38 spent longer time in open arms than those with saline, suggesting that this drug has an anxiolytic effect. In conclusion, the role of PACAP in the dorsal hippocampus can promote anxiety‐like behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Animal Behavior and Environmental Science, Graduate School of Agriculture, Meiji University, Kawasaki, Japan.
- Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Japan.
- Organization for the Strategic Coordination of Research and Intellectual Property, Meiji University, Kawasaki, Japan.
- Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo, Japan.
ORCID-Profile: Shuichi Chiba, Maiko Kawaguchi
Förderung
- Meiji University International Collaborative Research Promotion Project, Japan
- JSPS KAKENHI
Zitieren
APA
Sato, K., Chiba, S., Hatakeyama, T., Matsuwaki, T., Watanabe, G., & Kawaguchi, M. (2025). Administration of a Selective Antagonist for Pituitary Adenylate Cyclase‐Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12514
Vancouver
Sato K, Chiba S, Hatakeyama T, Matsuwaki T, Watanabe G, Kawaguchi M. Administration of a Selective Antagonist for Pituitary Adenylate Cyclase‐Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat. Neuropsychopharmacology Reports. 2025. doi:10.1002/npr2.12514
BibTeX
@article{Sato2025,
author = {Sato, Kaito and Chiba, Shuichi and Hatakeyama, Taichi and Matsuwaki, Takashi and Watanabe, Gen and Kawaguchi, Maiko},
title = {Administration of a Selective Antagonist for Pituitary Adenylate Cyclase‐Activating Polypeptide Receptor in the Hippocampus Causes Anxiolytic Effects in the Male Rat},
journal = {Neuropsychopharmacology Reports},
year = {2025},
doi = {10.1002/npr2.12514}
}
EUVIMED